Home / Contract Awards / Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

LeidosLogoLeidos (NYSE: LDOS) has been awarded a potential five-year, $23.7 million contract to support the U.S. Agency for International Development‘s efforts to research and develop a vaccine against malaria.

The company said Monday it will provide scientific and management services for USAID’s Malaria Vaccine Development Program under the cost-plus-fixed-fee contract.

Jerry Hogge, Leidos health deputy group president, said the company brings decades of life sciences technology and experience to the USAID program.

Leidos said the work to occur in Frederick, Maryland, could also evaluate malaria vaccine candidates during preclinical studies and clinical and field trials.

The company’s life sciences team supports medical product R&D efforts at the National Institutes of Health and the departments of Defense and Homeland Security.

Check Also

Sharon Hays Named Chief Technology, Strategy Officer at LMI; David Zolet

Sharon Hays, a senior fellow of LMI, has been named chief technology and strategy officer of the nonprofit consulting firm. She will lead the development of service offerings for the government sector, LMI said Tuesday.

IT Market Vet Chery Waldrup Joins Strongbridge as Chief Growth Officer

Cheryl Waldrup, former vice president of federal capture at General Dynamics' (NYSE: GD) information technology business, has joined information technology contractor Strongbridge as chief growth officer, G2XChange ETC reported Tuesday. She has more than two decades of IT and government contracting experience.